SZS. A. Zakharova

S. A. Zakharova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


S. A. Zakharova has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Efficacy of laughter therapy in elderly patients with late-life depression and dementia: a systematic review and meta-analysis

    by S. A. Zakharova, E. M. Novikova, Ya. V. Malygin, С. А. Захарова, Е. М. Новикова, Я. В. Малыгин

    The proportion of older people in the global population is increasing. High rates of depression and dementia, as well as the risks associated with pharmacotherapy, highlight the need for new, safe and effective therapeutic approaches. One such promising method is laughter therapy (LT). Objective: to evaluate, in this systematic review and meta-analysis, the effectiveness of laughter therapy (LT) in older patients with late-onset depression and dementia. Material and methods. A systematic literature search was conducted in the PubMed/MEDLINE and ProQuest databases (up to 28 May 2024). Studies were selected that included patients aged 60 years and over with late-onset depression, neurodegenerative diseases (Alzheimer’s disease, Pick’s disease) or dementia who underwent LT. Results. Five studies were included in the final analysis. In patients with late-onset depression undergoing LT, the increase in vitality was comparable to the results in the control group. The meta-analysis revealed a strong trend towards increased life satisfaction compared with the control group. LT reduces psychotic symptoms of dementia; however, it shows conflicting results regarding distress, agitation and aggression, and a worsening of disinhibition is also noted. LT has no significant effect on the behavioral and psychological symptoms of dementia as a whole. Standard treatment methods improve vitality more significantly in dementia. Conclusion. LT is a promising non-pharmacological treatment for late-onset dementia and depression, which may be preferable in cases where the use of pharmacotherapy is limited. However, LT requires monitoring for agitation and aggression in patients with dementia.

  • Open Access

    An example of a favorable outcome of a cervical spine injury occurring on a background of diffuse idiopathic skeletal hyperostosis: the result of an anthropological finding in the church of St. Peter in the town of Domashevo (Bosnia and Herzegovina)

    by O. A. Georginova, N. N. Goncharova, E. A. Grishanina, S. A. Zakharova, E. A. Makarov, T. N. Krasnova

    The article provides a description of the anthropological finding – human remains discovered in the church of St. Peter (Domashevo, Bosnia and Herzegovina, burial at the turn of the 15th and 16th centuries AD). The available morphological data most likely indicate the presence of diffuse idiopathic skeletal hyperostosis. This disease resulted in trauma to the cervical vertebrae, which altered their morphology. However, the injury did not lead to death; the person lived for a long time afterwards, as post-traumatic skeletal changes with the development of torticollis were noted.

  • Open Access

    Anemia in patients with inflammatory bowel disease as a risk factor for restless legs syndrome. Literature review

    by S. A. Zakharova, A. L. Kalinkin

    Restless legs syndrome (RLS) is a neurological, sensorimotor disorder. It is characterized by the uncomfortable and unpleasant sensations in the legs which begin or worsen during periods of rest, primarily in the evening or night, and are relieved by movement. Central iron deficiency plays a vital role in the pathogenesis of RLS. There is evidence that chronic inflammation is an additional risk factor for RLS. Anemia is the most common complication and extraintestinal manifestation of inflammatory bowel disease, therefore the prevalence of RLS in these patients is a problem of great interest. In addition, inflammatory bowel disease patients’ sleep disturbances directly influence the disease’s clinical course and can be the preclinical marker of exacerbation. It is essential for clinicians to be aware of RLS as a possible reason for sleep disturbance and as a factor that negatively affects the quality of life in inflammatory bowel disease patients.